ClinicalTrials.Veeva

Menu

ToT and Estrogen in Postmenopausal Females

K

Kasr El Aini Hospital

Status and phase

Completed
Phase 3
Phase 2

Conditions

Postmenopausal Disorder
Stress Urinary Incontinence

Treatments

Procedure: TVT-O

Study type

Interventional

Funder types

Other

Identifiers

NCT03295487
Saramohamed7880

Details and patient eligibility

About

To compare the subjective and objective outcomes of TVT-O procedure alone versus the same procedure followed by the use of premarin vaginal cream for 3 months in postmenopausal female with genuine stress incontinence.

Full description

a randomized controlled trial comparing the effect of using local estrogen cream after tot in postmenopausal female

Enrollment

210 patients

Sex

Female

Ages

49 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

-menopause patients included in group A should have: no history of breast cancer, ovarian cancer or uterine cancer No history of blood clots or thromboembolism No history of heart disease or stroke No history liver disease. Endometrial thickness less than 5mm Have a normal mammogram

Exclusion criteria

  • presence of urge or mixed incontinence .

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

210 participants in 2 patient groups

Group A
Active Comparator group
Description:
post menopausal female with genuine stress incontinence treated by TVT-O and local estrogen cream for 3 months after surgery
Treatment:
Procedure: TVT-O
Group B
Active Comparator group
Description:
post menopausal female with genuine stress incontinence treated by TVT-O only
Treatment:
Procedure: TVT-O

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems